On March 1, Missouri’s supply of a key execution drug expired. The sole U.S. manufacturer has stopped making the drug, sending the state on a quest to find more. The federal government does not have any reserves and is currently undertaking a review of what they call a critical shortage.
As St. Louis Public Radio’s Julie Bierach reports, Missouri has another option. It could follow the lead of Ohio and Oklahoma and switch drugs.